Hikal Ltd. has formally disclosed a significant restructuring within its promoter group. Castilia Life Sciences Private Limited (“Castilia Co”) has successfully converted into a Limited Liability Partnership (“Castilia LLP”). This conversion, approved by the Ministry of Corporate Affairs on February 17, 2026, resulted in the immediate vesting of all assets, liabilities, and the entire shareholding in Hikal Ltd. to the successor entity, Castilia LLP.
Corporate Restructuring: Conversion to LLP
Hikal Ltd. has reported a key ownership transition originating from its promoter group, necessitated by a formal change in the structure of one of its entities. The existing entity, Castilia Life Sciences Private Limited (“Castilia Co”), has officially converted into a Limited Liability Partnership, now known as “Castilia LLP”.
This conversion process received final approval from the Ministry of Corporate Affairs, which issued the Certificate of Registration on February 17, 2026.
Impact on Hikal Shareholding
As a direct consequence of this corporate conversion, the entire shareholding previously held by Castilia Co in Hikal Ltd. has been legally transferred and vested in the successor entity, Castilia LLP. This restructuring involves all associated assets, rights, and liabilities moving to the new LLP structure.
The filing confirms that Castilia LLP, as the successor entity, now holds the entire promoter stake. Prior to this, the holdings were substantial, detailed as 3,02,31,914 Equity Shares, representing 24.52% of the total equity of Hikal Ltd. The disclosure confirms that the mode of transfer was a change in the legal form of the promoter entity, not an open market transaction.
Regulatory Disclosure Details
The submission to the stock exchanges, dated February 18, 2026, serves as the required disclosure under the relevant insider trading regulations concerning changes in the holdings of a promoter group member. The disclosure form, submitted by Castilia Life Sciences LLP, was signed by Designated Partner, Sugandha Hiremath.
Source: BSE
